About Curavit
Curavit is a company based in Boston (United States) founded in 2019. Curavit has raised $16.43 million across 2 funding rounds from investors including Osage Venture Partners, Royal Street VC and Narrow Gauge Ventures. Curavit offers products and services including Stratus Platform and CRO Services. Curavit operates in a competitive market with competitors including Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Frontage Laboratories, among others.
- Headquarter Boston, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$16.43 M (USD)
in 2 rounds
-
Latest Funding Round
$5 M (USD), Series A
Nov 14, 2022
-
Investors
Osage Venture Partners
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Curavit
Curavit offers a comprehensive portfolio of products and services, including Stratus Platform and CRO Services.
HIPAA-compliant system for managing decentralized clinical trials remotely.
Suite for study design, recruitment, and data analysis in trials.
Funding Insights of Curavit
Curavit has successfully raised a total of $16.43M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Curavit
Curavit has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Osage Venture Partners, Royal Street VC and Narrow Gauge Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture capital fund investing in B2B software startups
|
Locked | Locked | Locked | |
|
Royal Street VC is engaged in early-stage venture capital investments.
|
Locked | Locked | Locked | |
|
Invests in startups addressing U.S. healthcare inefficiencies through technology.
|
Locked | Locked | Locked |
Investor details for Curavit
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Curavit
Investment portfolio details for Curavit
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Curavit
Detailed financials for Curavit
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Curavit Comparisons
Peer comparison for Curavit
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Curavit
Curavit operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Frontage Laboratories, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of drug discovery and preclinical development services
|
|
| Locked | Locked | Locked |
Data analysis and statistical solutions are provided for life sciences.
|
|
| Locked | Locked | Locked |
Provider of laboratory tests for physicians
|
|
| Locked | Locked | Locked |
Provider of clinical research, development, and commercialization services for life sciences
|
|
| Locked | Locked | Locked |
Early drug development services are provided for pharma firms.
|
|
| Locked | Locked | Locked |
Company offering specialised R&D and clinical development services for the development of precision medicine based drugs and devices
|
Detailed competitors of Curavit
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Curavit
Complete news archive for Curavit
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Curavit
Curavit was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Curavit is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Curavit is a funded company, having raised a total of $16.43M across 2 funding rounds to date.
Curavit was founded in 2019 in Boston, United States, as a virtual contract research organization focused on the clinical trials sector. Services including study design, regulatory support, patient enrollment, and remote monitoring via a central virtual site are offered. Health Economics and Outcomes Research for digital therapeutic trials is also provided, supporting decentralized operations across the industry.
Curavit's top competitors include LabCorp, Charles River Laboratories and Cytel.
Curavit offers Stratus Platform and CRO Services.
Curavit has 3 investors. Key investors include Osage Venture Partners, Royal Street VC, and Narrow Gauge Ventures.